Press release
Avascular Necrosis (AVN) Market Growth To be Driven By Increasing Alcohol Consumption and Use of Corticosteroids
Avascular necrosis (AVN), also called osteonecrosis, ischemic bone necrosis, or aseptic necrosis, is a condition that occurs due to loss of blood flow to the bone. The condition mostly occurs in the hip however, other common sites include ankle, knee, and shoulder. Individuals between the age of 20 and 50 years are more susceptible to avascular necrosis. Most cases of avascular necrosis occur due to an underlying health problem or injury. Moreover, factors such as increased intake of corticosteroids and alcohol may cause fatty substances to build in the blood vessels and decrease the blood supply to the bones, eventually causing avascular necrosis. Treatment for this condition depends on a number of factors, including age, disease stage, location, and amount of bone damage.Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2218
The global avascular necrosis market size was valued at US$ 512.9 million in 2017, and is expected to witness a CAGR of 6.0% over the forecast period (2018 – 2026).
Avascular Necrosis Market – Key Players Operating Global Market
Key players operating in the global avascular necrosis market include Bone Therapeutics, Boehringer Ingelheim GmbH, Bayer AG, Enzo Biochem Inc., Ethicon Inc., Eli Lilly and Company, Grifols SA, Integra LifeSciences Corporation, K-Stemcell Co Ltd., Medtronic Plc, Merck KGaA, Pfizer Inc., Sanofi SA, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings. Manufacturers are focusing on advancements in treatment technologies such as gene therapy and stem cell-based treatment for avascular necrosis.
Market Dynamics
Growth of avascular necrosis market is primarily driven by factors such as increasing incidence of avascular necrosis, high demand for non-invasive treatment, and increasing dependence on surgery to cure avascular necrosis. According to Bone Therapeutics report in 2017, around 170,000 patients were suffering from avascular necrosis in the U.S., Europe, and Japan. Moreover, side effects from various medicines taken during cancer, HIV/AIDS, osteoporosis, osteoarthritis, blood disorders, or medical treatment such as chemotherapy, radiation therapy, high-dosage of steroids, and organ transplants can increase chances of developing avascular necrosis. However, delay in diagnosis due to asymptomatic nature of this condition at early stage and high cost of surgical treatments for avascular necrosis are the major factors hampering growth of the avascular necrosis market.
Key features of the study:
This report provides in-depth analysis of the avascular necrosis market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global avascular necrosis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Bone Therapeutics, Boehringer Ingelheim GmbH, Bayer AG, Enzo Biochem Inc., Ethicon Inc., Eli Lilly and Company, Grifols SA, Integra LifeSciences Corporation, K-Stemcell Co Ltd., Medtronic Plc, Merck KGaA, Pfizer Inc., Sanofi SA, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global avascular necrosis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for avascular necrosis products, research and consulting firms, new entrants, and financial analysts
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Avascular Necrosis (AVN) Market Growth To be Driven By Increasing Alcohol Consumption and Use of Corticosteroids here
News-ID: 1307517 • Views: …
More Releases from Coherent Market Insights - Clinical Diagnostic

Western Blotting Market is Expected to Gain Popularity Across the Globe by 2026
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives…

Western Blotting Market: Future and Technological Advancement 2026 By Top Player …
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives…

Cannabis Testing Market Expansion to be Persistent During 2018 – 2026 With Top …
Cannabis testing is done for various purpose such as finding concentration of active ingredient (cannabinoids, terpene), which determines the medical potency of the cannabis. It is also tested for determining various other ingredient in given sample. For instance, to determine the pesticide residue content in the given sample that undermines the purity and efficacy. Cannabis testing also involves determination of contaminants such as fungi and bacteria (mycotoxins), which could causes…

Cannabis Testing Market Trends Estimates High Demand By 2026 With Top Key Player …
Cannabis testing products and services market is witnessing significant growth with increased government approval and loosening regulatory stringent ness over use of cannabis for commercial and recreational purpose. For instance, in February 2016, the Australian government amended the Narcotics Drugs Act 1967, to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favor the growth of the commercial manufacturing of cannabis…
More Releases for Avascular
Avascular Necrosis Market Set for Steady Growth Through 2034 | DelveInsight
Avascular Necrosis (AVN), also known as osteonecrosis, is a debilitating orthopedic disorder caused by the loss of blood supply to the bone, leading to bone tissue death and joint collapse. Commonly affecting the hip, AVN is often associated with trauma, long-term corticosteroid use, excessive alcohol intake, and underlying conditions such as lupus or sickle cell disease. Despite being relatively rare, AVN poses significant challenges due to delayed diagnosis, progressive pain,…
Avascular Necrosis Market 2024 Insights and Precise Outlook 2031
In recent years, increased alcohol intake, an increase in the frequency of fatal crashes and physical trauma, the growing popularity of advanced minimally invasive medical therapy, and excessive corticosteroid use are expected to boost the avascular necrosis market value. The global prevalence of osteonecrosis is increasing, as are the number of medicines approved by regulatory authorities, the market for non-invasive therapy, and the fraction of product offerings by market participants.…
Avascular Necrosis Market Driven by Tech Integration and Innovation
The global avascular necrosis market, valued at USD 611 million in 2021, is anticipated to reach USD 1,026 million by 2030. This growth trajectory represents a Compound Annual Growth Rate (CAGR) of 6.1% from 2022 to 2030. Avascular necrosis, also known as osteonecrosis, is a condition characterized by the death of bone tissue due to a lack of blood supply, leading to bone collapse and joint dysfunction.
REQUEST A $1000 DISCOUNT…
Avascular Necrosis Therapeutics Market - Revive your joints: Transforming avascu …
Newark, New Castle, USA: The "Avascular Necrosis Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Avascular Necrosis Therapeutics Market: https://www.growthplusreports.com/report/avascular-necrosis-therapeutics-market/8772
This latest report researches the industry structure,…
Avascular Necrosis Market Comprehensive Analysis of World Markets & Trade, 2028( …
Avascular necrosis is a condition in which bone tissue dies due to reduced blood flow to bones. Avascular necrosis also is known as osteonecrosis, bone necrosis, aseptic necrosis, and ischemic bone necrosis. Avascular necrosis commonly occurs in body sites such as hip, shoulder, ankle, and knees. Avascular necrosis is basically two type’s traumatic avascular necrosis and non-traumatic avascular necrosis. Avascular necrosis can be the result as reduction of blood supply…
Avascular Necrosis Market Stand Out As The Biggest Contributor In Healthcare
The global avascular necrosis market size was valued at US$ 512.9 million in 2017, and is expected to witness a CAGR of 6.0% over the forecast period (2018 – 2026).
Excessive alcohol consumption and long-term, high dose systemic corticosteroid use are the major risk factors for avascular necrosis. According to World Journal of Orthopedics, 2015, avascular necrosis usually affects people between 30 and 50 years of age. Also, from the same…